Michael S. Weiss - Jun 18, 2021 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Signature
/s/ Michael S. Weiss
Stock symbol
TGTX
Transactions as of
Jun 18, 2021
Transactions value $
$0
Form type
4
Date filed
6/22/2021, 06:26 PM
Previous filing
Jun 11, 2021
Next filing
Jul 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX COMMON STOCK Award $0 +1.08M +8.27% $0.00 14.1M Jun 18, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the final annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provided the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $500 million greater than the Market Capitalization on the date of grant as measured within a five-year timeframe, but in no event before December 1, 2022.
F2 Included in Mr. Weiss' beneficial ownership are 4,909,355 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a principal and beneficially owns a 50% interest.